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ABSTRACT Implicit solvent models approximate the effects of solvent through a potential of mean force and therefore make
solvated simulations computationally efﬁcient. Yet despite their computational efﬁciency, the inherent approximations made by
implicit solvent models can sometimes lead to inaccurate results. To test the accuracy of a number of popular implicit solvent
models, we determined whether implicit solvent simulations can reproduce the set of potential energy minima obtained from
explicit solvent simulations. For these studies, we focus on a six-residue amino-acid sequence, referred to as the paired helical
ﬁlament 6 (PHF6), which may play an important role in the formation of intracellular aggregates in patients with Alzheimer’s
disease. Several implicit solvent models form the basis of this work—two based on the generalized Born formalism, and one
based on a Gaussian solvent-exclusion model. All three implicit solvent models generate minima that are in good agreement
with minima obtained from simulations with explicit solvent. Moreover, free-energy proﬁles generated with each implicit solvent
model agree with free-energy proﬁles obtained with explicit solvent. For the Gaussian solvent-exclusion model, we demonstrate
that a straightforward ranking of the relative stability of each minimum suggests that the most stable structure is extended, a
result in excellent agreement with the free-energy proﬁles. Overall, our data demonstrate that for some peptides like PHF6,
implicit solvent can accurately reproduce the set of local energy minimum arising from quenched dynamics simulations with
explicit solvent. More importantly, all solvent models predict that PHF6 forms extended b-structures in solution, a ﬁnding
consistent with the notion that PHF6 initiates neuroﬁbrillary tangle formation in patients with Alzheimer’s disease.
INTRODUCTION
An appropriate representation of solvent is critical for
obtaining physiologically relevant results from biomolecular
simulations (1,2,3). The most straightforward approach for
modeling solvent is to explicitly include solvent molecules
in molecular dynamics (MD) simulations. However, molec-
ular simulations with explicit solvent increase the degrees of
freedom in the system and therefore can incur a signiﬁcant
computational cost. Consequently, a number of implicit sol-
vent models have been developed to reduce the computa-
tional complexity associated with solvated simulations. Such
models modify the potential energy function to reproduce the
effects of solvation without explicitly representing solvent
atoms (1,2). As simulations with implicit solvent models
have led to important insights, these models have gained
widespread acceptance in the ﬁeld of biomolecular simula-
tions (4). As evidence of this, the literature is replete with
studies that make conclusions based solely on data obtained
from such models (4). Recent studies, however, suggest that
implicit solvent models can sometimes lead to results that are
at odds with data obtained from explicit solvent simulations
and experimental observations (5,6,7). Therefore, it is likely
that not all implicit solvent models are appropriate for every
application. Moreover, the correct choice of solvent model
to use for any given problem likely depends on the system to
be studied, whether qualitative or quantitative results are
desired, and the degree of accuracy required.
In the study presented here, we explore whether confor-
mational sampling with implicit solvent models can yield
results similar to that obtained with explicit solvent simu-
lations. The solvent models that form the basis of this work
include: i), an early implementation of the generalized Born
(GB) model as described by Brooks and co-workers (8); ii),
an alternate implementation of the generalized Born formal-
ism that is based on an integral equation approach and that
employs a simple smooth switching function (GBSW) (9);
iii), the effective energy function-1 (EEF1) implicit solvent
model (10); and iv), the TIP3P model of explicit solvent (11).
The GB model uses a linearized form of Still’s equation to
estimate the electrostatic component of the solvation free
energy (8,12). The equation itself contains six independent
parameters that are varied to optimize agreement between
GB solvation energies and solvation energies calculated with
a ﬁnite-difference-Poisson-Boltzmann (FDPB) algorithm (8).
As the Born radius is inversely related to the atomic polar-
ization energy, Born radii can be calculated from the GB en-
ergies after parameter ﬁtting (8). The model has been widely
applied and its utility has been demonstrated in a number of
applications (13,14).
The GBSW model, like the GB model, is based on Still’s
equation; however, GBSW employs a more rigorous integral
equation approach to calculate the Born radii. In this method,
the electrostatic solvation energy of a given atom is expressed
as a sum of two terms—the self-solvation energy in the Cou-
lombic approximation plus a term that accounts for the reac-
tion ﬁeld (9). Each term is calculated using a surface/volumeSubmitted June 12, 2006, and accepted for publication September 19, 2006.
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integration that employs a smooth switching function at the
dielectric boundary to ensure numerical stability during mo-
lecular simulations (9). Unlike the GB method, the GBSW
model contains two adjustable parameters that dictate the
relative importance of the Coulombic ﬁeld term and the reac-
tion ﬁeld term (9). As before, the values of these parameters
were obtained by minimizing the least-square error between
GBSW energies and those calculated with a FDPB approach
(9). Once the optimal values of the adjustable parameters are
known, the Born radii can be calculated in a straightforward
manner. The current implementation of the GBSW algorithm
also incorporates a nonpolar contribution to the solvation free
energy using the solvent-exposed surface area of the protein
of interest, and a user-deﬁned surface tension coefﬁcient. The
GBSWmodel has been used to reﬁne model structures of the
C-terminal domain of Hsp33 protein, obtained from sparse
NMR data, into native-like folds that matched solved
structures (15). In addition, GBSW has been used to examine
intermolecular interactions between actin and myosin, lead-
ing to new observations regarding a mutation associated
with familial hypertrophic cardiomyopathy (16). Overall, the
model appears to be applicable to a broad range of problems.
EEF1 estimates the solvation free energy using a Gaussian
solvent-exclusion model (10). EEF1 expresses the solvation
free energy of a protein as a sum of group contributions, where
each contribution is equal to a reference solvation energy
(i.e., the solvation energy of the group alone) minus an inte-
gral over a solvation free-energy density function. The under-
lying assumption is that the integral over the free-energy
density is well approximated by a sum of Gaussian functions
(10). Important aspects of the model are that charged side
chains are neutralized and a distance-dependent dielectric is
used to further attenuate electrostatic interactions. The model
has been used in a number of applications, and interesting
results have been obtained.Most notably, EEF1 has been used
to calculate unfolding trajectories of proteins (17), discrim-
inate correctly folded from unfolded structures (18), and
probe the interactions between regions of a-lytic protease,
leading to a better understanding of the relative importance of
different interactions in stabilizing the native state (19).
In the study presented here, we address a speciﬁc, well-
deﬁned problem. We determine whether each of these sol-
vent models can reproduce the set of local energy minima
obtained from quenched MD (QMD) simulations with ex-
plicit solvent. To this end we perform QMD simulations with
each of the aforementioned implicit solvent models and
compare these results to those obtained with a TIP3P model
of solvent. We note that QMD is a widely used method for
locating local energy minima on a given potential surface.
The procedure consists of high-temperature MD simulations
(typically at 1000 K), followed by minimization of the re-
sulting structures (20). High-temperature simulations ensure
that a wide region of conformational space is sampled and
the subsequent minimizations assure that only local energy
minima are analyzed. Minimization can be performed by cou-
pling the system to a heat bath at 0 K (21,21,22), or by using
standard energy minimization algorithms such as steepest
descent or conjugate gradients (23). QMD has been used to
determine optimal positions and orientations of small func-
tional groups in the binding site of an enzyme (21), estimate
the density of states for proteins (24), and study the confor-
mational landscape of peptides and peptide analogs (22,23).
Our studies focus on a six-residue peptide commonly
referred to as paired-helical ﬁlament 6 (PHF6), which cor-
responds to the sequence found at the N-terminus of the third
microtubule-binding repeat domain of tau protein (306VQI-
VYK311). Tau protein forms intracellular aggregates (also
known as neuroﬁbrillary tangles) in patients with Alzheimer’s
disease (AD), and PHF6 corresponds to the minimal region
of tau needed for aggregation to occur in vitro (25,26,27). As
the formation of intracellular aggregates may be responsible,
in part, for neuronal death in patients with AD, the pre-
dominant low energy states of PHF6 are of particular interest
(28,29). In performing an analysis of PHF6, the goals of this
work are not only to evaluate the ability of several implicit
solvent models to reproduce energy minima on a potential
surface that explicitly models solvent, but also to determine
the most stable conformations of this peptide.
METHODS
Quenched molecular dynamics with
explicit solvent
Quenched molecular dynamics consisted of high temperature MD followed
by extensive minimization of the structures sampled during the trajectory. A
polar hydrogen model of the PHF6 peptide (VQIVYK) was created from
the CHARMM19 polar-hydrogen parameter set and initial coordinates for
PHF6 were built using the internal coordinate facility, all within CHARMM
(30). Both the N- and C-termini of the peptide were patched using NTERM
and CTERM patches, as is commonly done, resulting in charged termini
(i.e., NH31 and COO). The resulting structure was solvated with an
equilibrated set of TIP3P water molecules, and waters that overlapped with
the peptide or that were outside of a 19 A˚ radius were removed. A total of
823 water molecules was added to the system. A stochastic boundary setup
with a solvent sphere of radius 19 A˚ was used for these simulations (31). The
system was minimized, then heated and equilibrated for 1 ns at 1000 K.
Production dynamics were performed for an additional 10 ns at 1000 K.
Sampling at this temperature facilitates a broad exploration of the con-
formational space. The temperature was maintained by weakly coupling
(tcoup ¼ 5 ps) the system to a heat bath using the Berendsen method (32).
All explicit solvent simulations employed an electrostatic nonbond interac-
tion cutoff of 17 A˚, shifted between 14 A˚ and 16 A˚. Switching was used to
cut off van der Waals interactions at 16 A˚. SHAKE was used to hold hy-
drogen bond distances close to their equilibrium values and a 2 fs time step
was used (33).
Structures were chosen from the trajectory every 10 ps and subsequently
minimized, resulting in 1000 distinct minimum energy structures. Minimi-
zations were performed on the entire system consisting of the peptide and all
explicit water molecules. In addition, minimizations used the nonbond
speciﬁcations outlined above and consisted of 2500 steps of steepest de-
scent followed by 2500 steps of conjugate gradient minimization. A root
mean-square gradient cutoff of 0.01 kcal/mol/A˚ was set, such that if the
system achieved a root mean-square gradient below this value during the
minimization protocol, the minimization was terminated. The procedure for
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heating, equilibration, sampling, and minimization was identical for all of
the solvent models investigated in this study.
Quenched molecular dynamics in vacuum
Quenched molecular dynamics simulations were performed in vacuum (e ¼
1). Comparing the vacuum minima with minima obtained with the different
solvent models enabled us to assess the effects of the solvent models on the
structure of the peptide. The nonbond cutoffs and the minimization protocol
were identical to those used in the explicit solvent simulations.
Quenched molecular dynamics simulations with
implicit solvent
We performed a similar procedure for ﬁnding local energy minima on the
potential energy surface of each implicit solvent model described above.
One issue that needs to be resolved is the correct choice of simulation
conditions for each implicit solvent model. In general, we rely on prior data
to choose simulation conditions that optimize the chance that each implicit
solvent simulation would reproduce minima obtained from the explicit
solvent simulations. In this regard, we note that some temperature-coupling
algorithms may not be appropriate for all implicit solvent simulations (34).
In explicit solvent simulations with a Berendsen heat bath, the entire system,
consisting of both the solute and the solvent, are coupled to an external heat
bath. Implicit solvent simulations that utilize similar thermostats only couple
the peptide to an external bath as a continuum model is used for solvent. It
has been noted that some thermostats that couple the solute alone to a heat
bath may lead to diminished atomic ﬂuctuations, especially when the peptide
itself is tightly coupled (34). Diminished root mean-square (rms) ﬂuctuations
would clearly be disadvantageous for an approach that attempts to map local
energy minima on a large potential surface.
To determine whether a Berendsen thermostat with a coupling constant of
5 ps would be appropriate for our studies, we conducted MD simulations of
PHF6 with each implicit solvent model outlined above and compared these
data to simulations conducted with explicit solvent (when both the peptide
and solvent are coupled to an external bath). The resulting rms ﬂuctuations
were then compared to rms ﬂuctuations arising from the explicit solvent
simulations. For PHF6, the rms ﬂuctuations arising from all of the implicit
solvent simulations are in reasonable agreement with the rms ﬂuctuations
from the explicit solvent simulations (Fig. 1). As we are primarily interested
in mapping the local energy minima on the different potential energy sur-
faces, and not the dynamical properties of PHF6 in different models of
solvent, these data suggest that simulations with a Berendsen thermostat
would be appropriate for our studies.
Lastly we note that the precise model for the nonbond interactions for
each implicit solvent model was chosen based on prior data. The goal here
was to optimize the chance that each model would produce data in agree-
ment with the explicit solvent results.
Quenched molecular dynamics with GB: generalized Born simulations
utilized the implementation, and Born radii, originally described by
FIGURE 1 RMS ﬂuctuations for 100 ps simulation (100 ps equilibration, 100 ps production dynamics all at 300 K) of PHF6 in different solvent models
using a Berendsen heat bath. Simulation parameters, including nonbond cutoffs, are as listed in Methods. The average rms ﬂuctuation over all atoms is denoted
with a red line.
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Dominy et al. (8). As in our previous study (7), no truncation of
nonbond terms was used as this approach yields better results relative
to an approach that employs ﬁnite nonbond cutoffs (35).
Quenched molecular dynamics with GBSW: GBSW simulations used
the implementation previously described by Im et al. with a half
smoothing length of 0.3 A˚, a nonpolar surface tension coefﬁcient of
0.03 kcal/(mol 3 A˚2), and a grid spacing of 1.5 A˚ (9). Nonbond
cutoffs were set to 16 A˚ using a switching function for both van der
Waals and electrostatic interactions. Of the 1000 structures, the
minimization protocol described above failed for a single structure,
which was excluded from the analysis, yielding 999 distinct
structures. The singular failed structure was in a nonphysical confor-
mation corresponding to an energy of 1.3 3 1011 kcal/mol, whereas
all other structures had energies that were ,400 kcal/mol.
Quenched molecular dynamics with EEF-1: the EEF-1 implicit solvent
model was used as implemented in CHARMM (10,30). As the
nonbond cutoff parameters are integral to the model, the previously
described nonbond cutoffs were used here.
Generation of Ramachandran plots
Ramachandran density surfaces were created from the minima generated
from each of the quenched dynamics simulations. The f/c values for
residues Gln2-Tyr5 were calculated for each of the 1000 minima (999 for
GBSW), and a density function was computed using the SCATTERCLOUD
function (written by Steve Simon) obtained from the MATLAB central code
repository (http://www.mathworks.com/matlabcentral/). The densities were
normalized by their maximum values and rendered as surface plots using
MATLAB (The MathWorks, Natick, MA). Approximate secondary struc-
ture regions as deﬁned in Hovmo¨ller et al. (36) corresponding to a-helical
and b-structure are colored.
Generation of minimum pairwise distance plots
Histograms of minimum pairwise backbone rms deviations between minima
from different models (a reference model and a comparison model) were
computed. These histograms were used to determine whether each minimum
in the reference model was adequately represented by a structurally similar
minimum in the comparison model. For example, suppose explicit solvent is
the reference model and data arising from the EEF1 simulations are the
comparison model. The minimum pairwise distance (MPD) plot is used to
determine if each explicit solvent minimum is represented in the set of EEF1
minima. For each TIP3P minimum, we ﬁnd the EEF1 minimum with a
backbone conformation closest to the TIP3P minimum in question. This set
of rms deviations provides an objective assessment of how well the EEF1
minima reproduce the structures corresponding to the explicit solvent min-
ima. It is also of interest to determine the converse; i.e., whether each EEF1
minimum is well represented by an explicit solvent minimum. The converse
is computed by setting EEF1 as the reference model and the explicit solvent
results as the comparison model. If EEF1 generated many spurious minima
that did not correspond to explicit solvent minima, then the resulting
histogram of rms deviations would contain many large values. Therefore,
two sets of MPD plots were computed for each of the implicit solvent
models. In one set of calculations, the explicit solvent minima formed the
reference set, and in the other set of calculations, the implicit solvent model
served as the reference. Histograms were computed using MATLAB and
plots of aligned structures were constructed with Visual Molecular Dy-
namics (37).
Potential of mean-force calculations for PHF6
Free-energy proﬁles for PHF6 were computed for each solvent model. The
reaction coordinate for these simulations was the radius of gyration of the
peptide main-chain atoms. The simulations began by restraining the back-
bone to adopt an extended conformation with a radius of gyration of 5.5 A˚
using a harmonic constraining potential with a force constant of 25 kcal/mol/
A˚2. The system was then equilibrated at 300 K for 1 ns. The potential of
mean force (pmf) for a given solvent model was calculated by running a
series of simulations (windows), where the peptide is restrained to a different
radius of gyration using a harmonic force constant of 25 kcal/mol/A˚2. The
ﬁrst window was centered at 5.5 A˚ and subsequent windows began with the
ﬁnal state from the preceding window. The radius of gyration was decreased
by 0.1 A˚ for each new window. Restrained molecular dynamics for each
window involved 20 ps of equilibration followed by 80 ps of production
dynamics. Additional dynamics were performed to extend the pmf bound-
aries and improve sampling for regions of the pmf that exhibited dis-
continuities. Speciﬁcally, windows for extended states of the peptide were
run at 0.1 A˚ intervals for radius of gyration (rgyr) constraints ranging
between 5.6 A˚ and 6.6 A˚ to extend the boundaries of the pmf.
To compute the potential of mean force, the radius of gyration was
computed every 20 fs for each window of dynamics. From these data, a
biased probability density, ri* is computed and the potential of mean force,
Wi(j), is computed using the relation (31)
WiðjÞ ¼ kBT ln ri ðjÞ  ViðjÞ1Ci; (1)
where kB is Boltzmann’s constant, T is the temperature, Vi is the restraining
potential for window i, and Ci is a constant. To construct one continuous
potential of mean force, the different pmf from each window need to be
linked together—a process performed by the program SPLICE (38).
To determine that our pmf had converged, we performed additional
simulations for new windows constrained at rgyr that were offset 0.05 A˚
from the original window constraints and determined that this convergence
criterion was satisﬁed. Our metric for convergence of the pmf was based on
the location of the pmf minimum, since this is the primary quantity of
interest for this study. Speciﬁcally, we required that the location of the pmf
minimum changed by ,0.25 A˚ as the window step size was halved.
Representative structures from the global energy minimum in each pmf
were generated by ﬁrst averaging the structures sampled at the window
corresponding to the global energy minimum followed by minimization to
the nearest local energy minimum. All molecular ﬁgures were constructed
with Visual Molecular Dynamics (37).
Calculating vibrational entropies
Vibrational entropies were calculated from the 1000 distinct minima ob-
tained from EEF1 simulations. To ensure that only nonnegative eigenvalues
would be generated from the normal mode calculations, each minimum was
further minimized using 1000 steps of steepest descent minimization
followed by 2500 steps of adopted-basis Newton Rhapson minimization.
The corresponding Hessian matrix was then diagonalized to yield the normal
modes and their corresponding frequencies. The vibrational entropy for a









where N is the number of atoms in the system, h is Planck’s constant, kB
is Boltzmann’s constant, and fnig3N6i¼1 are the normal mode frequencies.
CHARMMwas used to create the Hessian matrix from minimized structures
and MATLAB was used to calculate vibrational entropies from the Hessian
matrix, yielding 1000 vibrational entropy measures; i.e., one for each mini-
mum (30).
We note that a harmonic analysis could only be performed on minima
arising from the EEF1 simulations, as second derivative calculations with
GB are not supported in CHARMMv32a2, and despite the extensive addi-
tional minimization, Hessian matrices for GBSW structures had negative
eigenvalues, thereby preventing a normal mode analysis.
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RESULTS
Minimum energy conformations with
explicit solvent
Minima on the potential energy surface of PHF6 were
obtained from high temperature molecular dynamics simu-
lations with explicit solvent followed by extensive minimi-
zation (i.e., quenched dynamics). After 10 ns of molecular
dynamics at 1000 K, a range of conformations was sampled
and subsequent energy minimization yielded 1000 distinct
structures corresponding to different local energy minima.
These structures span a range of conformations from the
compact, with a rgyr near 3 A˚, to a rgyr of almost 5.6 A˚
(Table 1). By contrast, minima arising from quenched mo-
lecular simulations in vacuum are relatively homogeneous
and have radii of gyration that are distributed over a narrow
range—between 3.0 A˚ and 3.5 A˚, suggesting that compact
states are overwhelmingly favored in the vacuum simula-
tions (Table 1).
To quantify the diversity among the different minimum
energy structures, we computed the backbone rms deviation
between all pairs of minima (Fig. 2). As we are interested in
distinguishing extended structures from compact structures,
in addition to secondary structural motifs sampled by the
peptide, we focus on comparisons of the backbone rms de-
viation between different pairs of conformers. These data
conﬁrm that the explicit solvent minima are considerably
more diverse than minima arising from the vacuum simu-
lations. In particular, the most extended structure from the
vacuum simulations has a radius of gyration of only 3.5 A˚
and contains a salt bridge between the N- and C-termini (Fig.
3). In vacuum, this salt bridge is exceptionally stable in that it
has an interaction energy near 90 kcal/mol and remains
intact even at 1000 K. Hence virtually all minima have this
salt bridge and the resulting vacuum structures are all
compact.
Minimum energy conformations with
implicit solvent
Minima arising from QMD simulations with implicit solvent
sample a range of radii of gyration that is similar to that
found in the set of explicit solvent minima (Table 1). A
comparison between representative minima from the differ-
ent solvent models further illustrates the close correspon-
dence between the implicit solvent results and the explicit
solvent results (Fig. 4); i.e., the backbone conformations of
the implicit solvent minima are similar to that arising from
the explicit solvent simulations.
The degree of similarity between the implicit solvent
minima and the TIP3P minima was quantiﬁed by computing
MPD plots. Each MPD plot is a histogram of the minimum
pairwise backbone rms deviations between minima from
two different models: a reference model and a comparison
model. For each minimum in the reference model, the closest
minimum in the comparison model is found and used to
generate a histogram of rms deviations. For example, in Fig.
5 A, the TIP3P minima is the reference model and the GB
minima is the comparison model. These data demonstrate
that every explicit solvent minimum is within 1.5 A˚ of a GB
minimum (Fig. 5 A). Fig. 5 A also shows an overlay of the
explicit solvent minimum that is farthest away from a GB
minimum; even for this worst case, the two minima have
very similar backbone conformations. MPD plots for the
other implicit solvent models reveal the same trend, i.e., each
explicit solvent minimum is within 1.3 A˚ of a GBSW
minimum (Fig. 5 B) and 1.5 A˚ from an EEF1 minimum (Fig.
5 C).
TABLE 1 Statistics of minima obtained from quenched









TIP3P 4.1 6 0.63 3.0 5.6
Vacuum 3.1 6 0.06 3.0 3.5
GB 4.7 6 0.46 3.2 5.7
GBSW 4.5 6 0.55 3.1 5.7
EEF1 4.7 6 0.47 3.4 5.9
FIGURE 2 Pairwise distance matrices between minimized structures from the (A) vacuum simulations and (B) explicit solvent simulations. Each pixel color
corresponds to a pairwise backbone RMS distance. The color scale is shown at the left of the ﬁgure.
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Although every explicit solvent minimum is close to an
implicit solvent minimum, it may be that the implicit solvent
simulations produce extraneous minima that do not corre-
spond to any minimum arising from the TIP3P simulations.
To determine whether the implicit solvent simulations pro-
duced such superﬂuous minima, the reverse comparison was
done, i.e., MPDs were computed with each implicit solvent
minima serving as the reference model and TIP3P serving as
the comparison model (Fig. 5, D–F). These data verify that
the implicit solvent simulations do not produce many
extraneous minima—that is, each implicit solvent minimum
is close to an explicit solvent minimum.
A conformational analysis of the TIP3P minima suggests
that the four residues in PHF6 with deﬁned f/c angles
(residues 2–5) preferentially sample regions of conforma-
tional space corresponding to b-structure (Fig. 6). Gln2, in
particular, is most likely to adopt f/c angles belonging to the
b-strand region of conformational space. The f/c densities
of the GB, GBSW, and EEF1 minima are similar to that
obtained from the TIP3P simulations in that b-strand con-
ﬁgurations are also favored (Fig. 6). By contrast, the vacuum
simulations yield minima where residues 2, 4, and 5 adopt
f/c angles that belong to the a-helical region of conforma-
tional space (Fig. 6).
Potential of mean-force calculations
Free-energy proﬁles were calculated for PHF6 in explicit
solvent to determine the predominant conformation of the
peptide in solution (Fig. 7). The reaction coordinate for these
simulations was the radius of gyration of the peptide. The
FIGURE 3 Structure of the most extended PHF6 minimum arising from
the vacuum simulations (rgyr ¼ 3.5 A˚).
FIGURE 4 Representative explicit solvent structures (blue) aligned with their closest implicit solvent structures. The ﬁrst row depicts the alignment of GB
(orche) minima to TIP3P minima; the second row shows the alignment of GBSW (cyan) minima to TIP3P; and the last row shows the alignment of EEF1
(purple) minima to TIP3P minima.
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global free-energy minimum of the peptide in explicit sol-
vent occurs at ;5.2 A˚, corresponding to a relatively ex-
tended conformation of the peptide (Fig. 7)—a ﬁnding
consistent with the f/c densities of explicit solvent minima.
The free-energy proﬁles calculated with each of the
implicit solvent models are similar to the pmfs calculated
with explicit solvent; i.e., each has a global minimum located
between 5 A˚ and 5.5 A˚ (Fig. 7). Average structures from
windows corresponding to the pmf minima conﬁrm that
these low energy structures are relatively extended (Fig. 8).
In addition, residues 2–5 from the average structure arising
from the explicit solvent pmf minimum have f/c angles that
fall within a region of conformational space consistent with
b-structure. The GBSW average structure, however, is least
similar to the average structure from the explicit solvent pmf
minimum (Fig. 8). The backbone rms deviation between the
GBSW pmf minimum and the TIP3P pmf minimum is ;2.7
A˚, whereas the GB and EEF1 structures are within 1 A˚ of the
TIP3P pmf minimum structure (Fig. 8). Hence, whereas all
of the implicit solvent models show qualitative agreement
with the explicit solvent pmf, the average structure arising
from EEF1 simulations at the global free-energy minimum is
most similar to the average structure obtained from cor-
responding simulations with explicit solvent.
Ranking minima from the implicit solvent models
Ideally, any sampling protocol designed to ﬁnd low energy
states on a potential surface should not only discover local
energy minimum, but it should also deduce which of the
resulting low energy structures are the most stable. In this
regard, we note that EEF1 and potentials based on the
generalized born formalism have been shown to correctly
identify the most stable protein conformation from sets
consisting of native and misfolded structures (18,41,42,43).
Moreover, a number of these studies suggest that the most
stable state can be deduced from static energy calculations on
energy-minimized structures (18,41,43). Given these obser-
vations, we explored whether static energy calculations on
the different implicit solvent minima could provide enough
information for identifying the most stable conformation.
A comparison of the relative energies of the different
minima is shown in Fig. 9. Both the GB and GBSW minima
have a number of low energy states that are within 2 kcal/mol
FIGURE 5 MPDplots (see text). The reference and com-
parison sets are labeled. In each case, the two structures
having the greatest RMS difference are overlaid.
40 Huang and Stultz
Biophysical Journal 92(1) 34–45
of the lowest energy structure, and all of these conformations
are relatively compact with radii of gyration near 3.5 A˚ (Fig.
9). By contrast, the set of EEF1 minima contains a prominent
minimumwith a radius of gyration of 5.08 A˚, a value close to
the global free energy minimum in the EEF1 and TIP3P free
energy proﬁles (Fig. 9). Hence the most stable conformation
of PHF6 can be identiﬁed from an analysis of the EEF1
energies alone.
We note that methods that identify the most stable
conformation of a protein from static energy evaluations on
distinct energy-minimized conformers typically assume that
the solute entropy at each local energy minimum is roughly
the same, and therefore can be ignored (42,44,45). Such
approximations may be valid for a number of proteins, but it
is not clear whether such a premise is valid for small peptides
like PHF6 (44,45). Although static energy calculations with
EEF1 lead to results that agree with calculated free energy
proﬁles, this does not necessarily imply that the solute
entropy is the same at each minimum. Therefore, to explore
the role that the solute entropy has in determining the relative
stability of the PHF6 minima, we computed the vibrational
entropy of each EEF1 minimum within the context of a
harmonic approximation (40). The relative free energy of
each minimum was then estimated using the sum of the
internal energy (i.e., the EEF1 energy) and the vibrational
entropy (Table 2). Ranking the EEF1 minima using this new
measure leads to conclusions that are identical to what was
obtained from an analysis of the EEF1 energies alone. In
particular, the lowest energy conformations are extended,
and the lowest energy structure is the same (Table 2).
However, as is clear from Table 2, the vibrational entropy
spans a range of more than 10 kcal/mol, a somewhat larger
range than was noted in prior studies on proteins (44,45).
Including the vibrational entropy also leads to a change in the
ranking of the PHF6 minima. Consequently, even though our
results are similar to those seen when the vibrational entropy
is explicitly included, it is clear that it can play a role in
determining the relative ordering of different minima.
DISCUSSION
Given their considerable computational efﬁciency, a number
of problems can be approached with the aid of implicit sol-
vent models that would be intractable if only explicit solvent
models were available (13–19). However, not all implicit sol-
vent models are created equal, and some may be more ap-
propriate for particular problems. As such, studies, such as
the work presented here, which aim to delineate the limi-
tations as well as the advantages of different implicit solvent
models, may help to decide which model to use for any given
application.
This study was designed to address a speciﬁc question–
namely, could selected implicit solvent models adequately
reproduce the set of local energy minima found on a potential
surface that explicitly includes solvent. Toward this end, we
mapped local energy minima on different potential surfaces
and compared these minima to minima obtained from sim-
ulations with explicit solvent. We found that GB, GBSW,
and EEF1 performed quite admirably in that they were able
to successfully reproduce the set of minima obtained from
explicit solvent simulations. Ramachandran plots of the
resulting structures conﬁrm that all solvent models sampled
similar regions of conformational space. Furthermore, free-
energy proﬁles obtained from all three implicit solvent
models were in good agreement with free-energy proﬁles
obtained with explicit solvent. However, visual inspection of
the structures suggests that EEF1 provides a slightly more
accurate representation of the most favored conformations
on the peptide’s free energy surface.
All of the implicit solvent simulations generate pmfs that
are in good agreement with the explicit solvent simulations
in a fraction of the central processing unit (CPU) time
required for the explicit solvent simulations (Fig. 10 A). Of
the different implicit solvent simulations, EEF1 required
FIGURE 6 Comparison of normalized f/c densities of minima ob-
tained by quenched molecular dynamics for residues Gln2-Tyr5. The region
corresponding to the b-structure peak is colored red and the region
corresponding to the a-helix peak is colored green. Following the secondary
structural deﬁnitions used in Hovmo¨ller et al. (36), the region of b-sheet
conformations consists of f/c angles within the range of f ¼ [180, 45]
and c¼ [45, 225] and the region of a-helix conformations consists of f/c
angles within the range of f ¼ [180, 0] and c ¼ [100, 45].
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the least CPU time (Fig. 10 B). This is due, in part, to the
different nonbond cutoffs in each model. As the nonbond
speciﬁcations in EEF1 are part of the model, all EEF1 sim-
ulations employ a relatively short cutoff of 9 A˚ (10). The
nonbond cutoffs for the GB and GBSW models were con-
siderably larger. The GB simulations employed an inﬁnite
cutoff because it has been shown that this cutoff scheme
yields results that are in good agreement with explicit solvent
for some systems (35). The GBSW simulations used a ﬁnite
nonbond cutoff of 16 A˚ because this value leads to rea-
sonable computation times with relatively small errors in the
calculated forces (9). Nevertheless, a 16 A˚ cutoff for a small
peptide like PHF6 leads to almost no truncation of the
nonbond terms. As a result, the nonbond lists for the GB and
GBSW simulations are quite similar. The longer simulation
time for GBSW is due to the fact that, unlike GB, GBSW
employs a relatively expensive surface/volume integration to
calculate the electrostatic contribution to the solvation
energy (8,9).
To determine whether the most stable state of PHF6 could
be identiﬁed from an analysis of the minima alone without
additional umbrella sampling, we examined the relative
energies of minima arising from each implicit solvent sim-
ulation. The lowest energy structure from the set of EEF1
minima is extended and has a radius of gyration near that
found in the free-energy proﬁles. By contrast, the lowest
energy structures from the GB and GBSW simulations are
relatively compact. Hence, for PHF6, one could correctly
deduce that extended structures are most stable from an
analysis of the EEF1 energies alone. These data are encour-
aging as they suggest that an analysis of minima obtained
from simulations with EEF1 may provide insights that are
FIGURE 7 Potential of mean force
plots for the different solvent models
analyzed in this study.
FIGURE 8 Representative structures from the simulation windows corre-
sponding to the global free energy minimum in each pmf. The backbone rms
deviation from the TIP3P structure is explicit shown for each of the implicit
solvent structures.
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comparable to what one would obtain from umbrella sam-
pling calculations with explicit solvent—a considerably more
taxing approach.
It should be noted that this conclusion may not be
generally applicable. Ranking EEF1 minima based solely on
static EEF1 energies assumes that the solute entropy at each
minimum can be safely ignored. However, estimates of the
vibrational entropy reveal that the solute entropy can vary
signiﬁcantly at each minimum. Although our conclusions are
the same when the vibrational entropy of each minimum is
explicitly calculated, the ranking of the EEF1 minima is
somewhat altered when this is done. Therefore, we cannot
rule out that estimates of the solute entropy are needed to
accurately identify the most stable conformation of other
peptides. In this regard, we note that static energy evalua-
tions of GB and GBSW minima lead to conclusions that
differ from that obtained from the pmf calculations in explicit
solvent. As normal mode analyses could not be performed on
GB and GBSW minima, it may be that more accurate results
could be obtained if a vibrational analysis was performed on
these minima.
In our previous study, we found that both EEF1 and GB
were unable to reproduce the free-energy proﬁle obtained
from simulations with explicit solvent using a different
peptide system (7). In that work, we used umbrella sampling
calculations with explicit solvent to calculate a peptide’s
potential of mean force as a function of its radius of gyration
(7). The FRET efﬁciency for this peptide, which was cal-
culated from the pmf, was in excellent agreement with
experiment. Central to the success of the explicit solvent
simulations was the formation of a stable salt bridge between
glutamate 5 and arginine 11. By contrast, in both the GB and
EEF1 simulations, the formation of a glutamate-arginine salt
bridge was unfavorable, and consequently simulations with
these implicit solvent models lead to calculated FRET
efﬁciencies that disagreed with the explicit solvent results
(7). Although the solvation energy of individual side chains
is likely well modeled by these implicit solvation models, it
is not clear that energetics of salt-bridge formation is
appropriately modeled by these approaches (7,46). This may
be particularly true for salt-bridges that involve arginine
residues (46). As such, the absence of multiple charged side
chains in the sequence of PHF6 likely explains the difference
between the results presented in this work and those of our
prior work. For PHF6, representative structures from the
FIGURE 9 Relative energies of min-
ima from each implicit solvent simula-
tion. The radii of gyration of the low
energy structures in each solvent model
are explicitly shown. The structure of
the lowest energy minimum arising
from the EEF1 simulations is explicitly
shown.
TABLE 2 EEF1/vibrational energies of selected EEF1 minima;








A ¼ E  TSvib
(kcal/mol)
1 5.08 191.93 23.22 215.15
2 4.90 177.75 33.31 211.06
3 5.16 185.81 24.92 210.73
4 5.03 186.17 24.53 210.70
5 5.10 185.98 23.82 209.80
15 5.04 186.03 22.63 208.66
38 5.01 177.09 30.60 207.69
64 4.45 185.74 20.99 206.73
141 4.46 172.93 32.45 205.37
843 3.99 175.72 20.53 196.25
Implicit Solvent Models and Tau 43
Biophysical Journal 92(1) 34–45
lowest energy state within the explicit solvent pmf contain
one salt-bridge between the side chain of lysine 6 and the
C-terminal carboxyl of the same residue (Fig. 8). Therefore,
the explicit solvent pmf suggests that the lowest energy state
is extended without any salt bridges or hydrogen bonds
between moieties that are separated in the sequence. This
simple extended state that lacks salt bridges or hydrogen
bonds between distant residues is well modeled by the
implicit solvent models investigated in this work.
All of the solvent models predict that PHF6 preferentially
adopts extended structures in solution, and a conformational
analysis of amino-acids in PHF6 argues that residues 2–5
adopt f/c values corresponding to the b-strands. These
ﬁndings have important implications for the pathogenesis
of neuroﬁbrillary tangle formation in patients with AD. In
particular, there is growing consensus that the ability of
amyloidogenic proteins like tau to aggregate stems from
properties of the protein backbone. In many instances, pro-
tein aggregation requires the formation of intermolecular
backbone hydrogen bonds yielding a cross b-structure (i.e.,
the b-strands are perpendicular to the axis of the ﬁbril), and
for tau this process is likely important for the initiation of
neuroﬁbrillary tangle formation (47,48,49).
Our ﬁndings imply that PHF6 exhibits a strong preference
for extended b-structures in solution—a ﬁnding that sug-
gests that PHF6 promotes neuroﬁbrillary tangle formation by
facilitating the formation of cross b-structure between tau
monomers. This premise is consistent with recent data sug-
gesting that the sequence of PHF6 is the minimal region of
tau required for tau aggregation into cross b-ﬁlaments and
hence neuroﬁbrillary tangles (25). As neuroﬁbrillary tangle
formation may play a role in neurodegeneration (28),
therapies directed at modifying the structural preference for
PHF6 may lead to new treatments for dementias like AD and
the tauopathies (50).
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